𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Effect of levodopa on both verbal and motor representations of action in Parkinson’s disease: A fMRI study

✍ Scribed by Péran, P.; Nemmi, F.; Méligne, D.; Cardebat, D.; Peppe, A.; Rascol, O.; Caltagirone, C.; Demonet, J.F.; Sabatini, U.

Book ID
122694507
Publisher
Elsevier Science
Year
2013
Tongue
English
Weight
475 KB
Volume
125
Category
Article
ISSN
0093-934X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Study of istradefylline in patients with
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
✍ Robert A. Hauser; Lisa M. Shulman; Joel M. Trugman; John W. Roberts; Akihisa Mor 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 1 views

## Abstract The objective of this study was to evaluate the efficacy, safety, and tolerability of istradefylline 20 mg once daily versus placebo as an adjunct to levodopa in subjects with Parkinson's disease (PD) who have motor fluctuations. Istradefylline (KW‐6002) is an adenosine A~2A~ receptor a

Longitudinal study of the motor response
Longitudinal study of the motor response to levodopa in Parkinson's disease
✍ Benjamin G. Clissold; Craig D. McColl; Katrina R. Reardon; Mark Shiff; Peter A. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 1 views

## Abstract In this prospective study of 34 patients with Parkinson's disease, measurements of the short duration levodopa motor response have been performed in defined __off__ states at 3 yearly intervals over a mean period of 11.4 years from the point of commencement of levodopa treatment. Twenty

Modulatory effect of clozapine on levodo
Modulatory effect of clozapine on levodopa response in parkinson's disease: A preliminary study
✍ Gonzalo J. Gomez Arevalo; Dr. Oscar S. Gershanik 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 553 KB

## Abstract Clozapine has been shown not only to be effective in ameliorating dopaminomimetic psychosis but to improve parkinsonian symptomatology. Six parkinsonian patients with motor fluctuations under levodopa treatment and severe interdose “off” periods (believed to be mediated by an inhibitory